News | March 01, 2024
Pfizer Oncology hosts innovation day
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Total transaction value of the divestment is Rs. 3,660 million
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Good momentum in commercial CDMO business
Subscribe To Our Newsletter & Stay Updated
